ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

96 hedge funds and large institutions have $130M invested in Aclaris Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-12
Holders Change %
-11.11%
% of All Funds
1.29%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
24
Increased
30
Reduced
28
Closed
36
Calls
$5K
Puts
–
Net Calls
+$5K
Net Calls Change
-$29K

Top Buyers

1
BlackRock
BlackRock
New York
+$5.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.4M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.82M
4
Morgan Stanley
Morgan Stanley
New York
+$1.6M
5
PAI
Palo Alto Investors
California
+$872K

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$7.14M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.79M
3
MIM
Monashee Investment Management
Massachusetts
-$1.36M
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$1.19M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$706K
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
$886K +$178K +125,071 +25%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$723K -$1.19M -841,470 -62%
SCM
28
Stonepine Capital Management
Oregon
$698K -$51.9K -36,542 -7%
CF
29
Cantor Fitzgerald
New York
$641K -$347K -244,453 -35%
BCM
30
Bridgeway Capital Management
Texas
$630K +$220K +154,600 +54%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$628K -$22.6K -15,937 -3%
ACM
32
Aisling Capital Management
New York
$617K – – –
Squarepoint
33
Squarepoint
New York
$555K +$59.2K +41,666 +12%
HighTower Advisors
34
HighTower Advisors
Illinois
$457K +$8.17K +5,753 +2%
Raymond James Financial
35
Raymond James Financial
Florida
$394K +$37.6K +26,454 +11%
Charles Schwab
36
Charles Schwab
California
$371K +$324K +228,219 +690%
NL
37
Nuveen LLC
North Carolina
$338K +$338K +237,830 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$306K +$286K +201,689 +1,486%
Dimensional Fund Advisors
39
Dimensional Fund Advisors
Texas
$295K -$210K -147,576 -42%
Assenagon Asset Management
40
Assenagon Asset Management
Luxembourg
$262K -$706K -496,968 -73%
T. Rowe Price Associates
41
T. Rowe Price Associates
Maryland
$237K +$61.6K +43,267 +35%
Goldman Sachs
42
Goldman Sachs
New York
$222K -$567K -399,381 -72%
Barclays
43
Barclays
United Kingdom
$222K +$53K +37,336 +31%
UBS Group
44
UBS Group
Switzerland
$218K +$112K +79,180 +107%
Invesco
45
Invesco
Georgia
$192K +$111K +78,250 +137%
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
$172K -$1.79M -1,260,594 -91%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$121K +$121K +84,965 New
Bank of America
48
Bank of America
North Carolina
$103K -$135K -95,074 -57%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$91K +$91K +64,200 New
Wells Fargo
50
Wells Fargo
California
$89.2K +$82.7K +58,250 +1,269%
1
2
3 4 5